Madrigal Pharmaceuticals
MDGL
MDGL
148 hedge funds and large institutions have $2.27B invested in Madrigal Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
38% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 34
8.81% more ownership
Funds ownership: 44.46% → 53.27% (+8.8%)
Holders
148
Holding in Top 10
6
Calls
$55.4M
Puts
$8.65M
Top Buyers
| 1 | +$155M | |
| 2 | +$137M | |
| 3 | +$107M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$104M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$55.8M |
Top Sellers
| 1 | -$55.9M | |
| 2 | -$50.1M | |
| 3 | -$44M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$33.7M |
| 5 |
State Street
Boston,
Massachusetts
|
-$33M |